Form 4 for BSX Boston Scientific
Accepted 2026-05-11 16:32:12 ET · period of report 2026-05-07 · accession 0001225208-26-005110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-11 16:32 | 2026-05-07 | BSX | Morano Susan E | Dir | A - Grant | $0.00 | +5,081 | 11.7K | +76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-07 | A | A | 3,800 | $0.00 | 10,463 | D | — | — | (F1) Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant. |
| 2 | Common | Common Stock | 2026-05-07 | A | A | 1,281 | $0.00 | 11,744 | D | — | — | (F2) Grant of restricted stock in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of approximately $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant. |